ISG12a mediates cell response to Newcastle disease viral infection

Nianli Liu1, Ying Long2, Bin Liu2

  • 1Department of Molecular Medicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, China; Research Center of Cancer Prevention & Treatment, Translational Medicine Research Center of Liver Cancer, Hunan Provincial Tumor Hospital (Affiliated Tumor Hospital of Xiangya Medical School of Central South University), Changsha 410013, China.

Virology
|July 8, 2014
PubMed

Insights

Newcastle disease virus (NDV) oncolysis in cancer cells depends on interferon responses. Low interferon-stimulated gene 12a (ISG-12a) levels promote NDV oncolysis, suggesting therapeutic potential.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Newcastle disease virus (NDV) is a promising oncolytic virus, with its efficacy potentially linked to the host's Type I interferon (IFN) response.
  • Hepatocellular carcinoma (HCC) is a major global health concern, and understanding viral oncolysis mechanisms in HCC is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of Type I interferon response, specifically interferon-stimulated gene 12a (ISG-12a), in Newcastle disease virus (NDV) oncolysis of hepatocellular carcinoma (HCC) cells.
  • To compare the susceptibility of TRAIL-resistant and TRAIL-sensitive HCC cells to NDV oncolysis and elucidate the underlying IFN-related mechanisms.

Main Methods:

  • Comparative analysis of TRAIL-resistant and TRAIL-sensitive HCC cell lines.
  • Assessment of NDV replication and oncolysis.
  • Investigation of basal and induced expression of ISG-12a.
  • Manipulation of ISG-12a expression (over-expression and silencing).
  • Evaluation of the roles of RIG-I and Noxa in NDV oncolysis.

Main Results:

  • TRAIL-resistant HCC cells, with lower basal ISG-12a expression, were more susceptible to NDV oncolysis than TRAIL-sensitive cells.
  • Over-expression of ISG-12a in TRAIL-resistant cells reduced NDV replication but enhanced oncolysis, while ISG-12a silencing in TRAIL-sensitive cells had opposite effects.
  • RIG-I and Noxa were identified as contributing factors to NDV oncolysis.

Conclusions:

  • Basal levels of ISG-12a significantly influence NDV oncolysis, with low levels promoting viral replication and subsequent oncolysis.
  • ISG-12a modulation presents a potential therapeutic strategy to enhance NDV oncolysis in HCC.
  • The interplay between IFN response, viral replication, and cell death pathways is critical for effective oncolytic virotherapy.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
64.3K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
56